Trial Outcomes & Findings for Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement (NCT NCT04602741)

NCT ID: NCT04602741

Last Updated: 2026-05-22

Results Overview

Number of participants retained in the study through to post-intervention evaluation. The target is retaining 85% of participants recruited.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

91 participants

Primary outcome timeframe

6 months per participant in a 27 month period.

Results posted on

2026-05-22

Participant Flow

Participant milestones

Participant milestones
Measure
A4i Intervention
App4Independence (A4i) Experimental: A4i Intervention App4Independence (A4i) The study intervention is the digital health platform A4i. A4i operates on the individual's own phone with or without data. Specific A4i functionality includes: * Addressing social isolation and cognitive challenges through personalized prompts, scheduling of activities, and connections to a range of resources. * Fostering illness self-management through evidence-informed content. * A peer-peer engagement platform that facilitates strategy/tip sharing between users (anonymous and moderated). * Daily wellness and goal attainment check-ins. * An ambient sound detector with an oscilloscope-type indicator that assists individuals with auditory hallucinations separate hallucinations from real sounds. * Passively collected data on phone use as a proxy for sleep. * A provider dashboard. Both control and experimental condition participants will be receiving standard outpatient care (TAU). A4i Intervention: 6 months of the provision of A4i on the individual's own device.
Treatment As Usual
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
Overall Study
STARTED
43
48
Overall Study
COMPLETED
26
41
Overall Study
NOT COMPLETED
17
7

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
A4i Intervention
n=43 Participants
App4Independence (A4i) Experimental: A4i Intervention App4Independence (A4i) The study intervention is the digital health platform A4i. A4i operates on the individual's own phone with or without data. Specific A4i functionality includes: * Addressing social isolation and cognitive challenges through personalized prompts, scheduling of activities, and connections to a range of resources. * Fostering illness self-management through evidence-informed content. * A peer-peer engagement platform that facilitates strategy/tip sharing between users (anonymous and moderated). * Daily wellness and goal attainment check-ins. * An ambient sound detector with an oscilloscope-type indicator that assists individuals with auditory hallucinations separate hallucinations from real sounds. * Passively collected data on phone use as a proxy for sleep. * A provider dashboard. Both control and experimental condition participants will be receiving standard outpatient care (TAU). A4i Intervention: 6 months of the provision of A4i on the individual's own device.
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
Total
n=91 Participants
Total of all reporting groups
Age, Continuous
32.5 years
STANDARD_DEVIATION 12.6 • n=2 Participants
29.2 years
STANDARD_DEVIATION 9.0 • n=4 Participants
30.8 years
STANDARD_DEVIATION 10.9 • n=6 Participants
Sex/Gender, Customized
man
27 Participants
n=2 Participants
27 Participants
n=4 Participants
54 Participants
n=6 Participants
Sex/Gender, Customized
woman
14 Participants
n=2 Participants
18 Participants
n=4 Participants
32 Participants
n=6 Participants
Sex/Gender, Customized
non-binary
2 Participants
n=2 Participants
3 Participants
n=4 Participants
5 Participants
n=6 Participants
Race/Ethnicity, Customized
White European Origin
16 Participants
n=2 Participants
20 Participants
n=4 Participants
36 Participants
n=6 Participants
Race/Ethnicity, Customized
Afro-Caribbean or African Origin
11 Participants
n=2 Participants
7 Participants
n=4 Participants
18 Participants
n=6 Participants
Race/Ethnicity, Customized
Indigenous
3 Participants
n=2 Participants
1 Participants
n=4 Participants
4 Participants
n=6 Participants
Race/Ethnicity, Customized
Other
13 Participants
n=2 Participants
20 Participants
n=4 Participants
33 Participants
n=6 Participants
Region of Enrollment
Canada · Born in Canada
31 Participants
n=2 Participants
33 Participants
n=4 Participants
64 Participants
n=6 Participants
Region of Enrollment
Canada · Born Elsewhere
12 Participants
n=2 Participants
15 Participants
n=4 Participants
27 Participants
n=6 Participants
Employment
Unemployed
17 Participants
n=2 Participants
17 Participants
n=4 Participants
34 Participants
n=6 Participants
Employment
Employed (incl. Self-Employed)
12 Participants
n=2 Participants
15 Participants
n=4 Participants
27 Participants
n=6 Participants
Employment
Volunteer Work/Unpaid
2 Participants
n=2 Participants
1 Participants
n=4 Participants
3 Participants
n=6 Participants
Employment
Student
11 Participants
n=2 Participants
13 Participants
n=4 Participants
24 Participants
n=6 Participants
Employment
Other
1 Participants
n=2 Participants
2 Participants
n=4 Participants
3 Participants
n=6 Participants
Relation Status
Single/Separated/Divorced/Widowed
38 Participants
n=2 Participants
35 Participants
n=4 Participants
73 Participants
n=6 Participants
Relation Status
Married/In a Relationship/Cohabitating with a Partner
5 Participants
n=2 Participants
13 Participants
n=4 Participants
18 Participants
n=6 Participants
Education
High School or Below
15 Participants
n=2 Participants
13 Participants
n=4 Participants
28 Participants
n=6 Participants
Education
University
23 Participants
n=2 Participants
34 Participants
n=4 Participants
57 Participants
n=6 Participants
Education
Graduate School
5 Participants
n=2 Participants
1 Participants
n=4 Participants
6 Participants
n=6 Participants
Diagnosis
Schizophrenia
21 Participants
n=2 Participants
25 Participants
n=4 Participants
46 Participants
n=6 Participants
Diagnosis
Schizophreniform
3 Participants
n=2 Participants
3 Participants
n=4 Participants
6 Participants
n=6 Participants
Diagnosis
Schizoaffective Disorder
9 Participants
n=2 Participants
13 Participants
n=4 Participants
22 Participants
n=6 Participants
Diagnosis
Other Specified Psychotic Disorder
10 Participants
n=2 Participants
7 Participants
n=4 Participants
17 Participants
n=6 Participants

PRIMARY outcome

Timeframe: Through recruitment process an average of 1 week during a 21 month recruitment period.

Number of individuals successfully recruited into the trial with a target of 91.

Outcome measures

Outcome measures
Measure
Participants
n=96 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
Recruitment
91 Participants

PRIMARY outcome

Timeframe: 6 months per participant in a 27 month period.

Number of participants retained in the study through to post-intervention evaluation. The target is retaining 85% of participants recruited.

Outcome measures

Outcome measures
Measure
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
Retention
26 Participants
41 Participants

PRIMARY outcome

Timeframe: Up to 6 months.

Population: 0 individuals from the TAU group were analyzed since they did not have access to the mobile A4i intervention

Number of interactions with the app will be collected including information on the combined time and frequency of use for each participant.

Outcome measures

Outcome measures
Measure
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
App Interactions
14.9 interactions
Standard Deviation 21.8

PRIMARY outcome

Timeframe: Up to 6 months.

Safety/tolerability will be assessed through information gathered via all study-related interactions with significant safety concerns operationalized as one or more critical incidents occurring in which there is evidence of an association between the incident and App use.

Outcome measures

Outcome measures
Measure
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
Incidence of Treatment-Emergent Adverse Events
0 Participants
0 Participants

PRIMARY outcome

Timeframe: Up to 6 months.

Population: 0 individuals from the TAU group were analyzed since they did not have access to the mobile A4i intervention

Total number of posts liked for each participant will be collected.

Outcome measures

Outcome measures
Measure
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
App Likes
24.6 app likes
Standard Deviation 70.5

SECONDARY outcome

Timeframe: Baseline-6 months.

General symptomatology will be assessed using the 53-item, 5-point likert scale Brief Symptom Inventory. Range 0-212. Lower values are better.

Outcome measures

Outcome measures
Measure
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
BSI: Psychiatric Symptoms
Pre-Intervention
53.0 score on a scale
Standard Deviation 38.7
61.5 score on a scale
Standard Deviation 40.5
BSI: Psychiatric Symptoms
Post-Intervention
39.4 score on a scale
Standard Deviation 34.3
53.3 score on a scale
Standard Deviation 42.8
BSI: Psychiatric Symptoms
Pre-Post Change
-13.7 score on a scale
Standard Deviation 23.4
-7.4 score on a scale
Standard Deviation 35.1

SECONDARY outcome

Timeframe: Baseline-6 months.

Medication adherence will be measured using the 4-item Brief Adherence Rating Scale with responses obtained by both providers and participants to assess medication adherence. There are two indicators, both are pre-post changes, "days not taken" and "days taken less", and both are not scored as a percentage. The change scores for taking medication less (days taken less) and medication not taken (days not taken) were calculated as the difference from their 6 month score minus their baseline score. An value of "better" was assigned when the change score is \> 0, value of "no change" was assigned when the change score is = 0, and a value of "worse" value was assigned when the change score is \< 0.

Outcome measures

Outcome measures
Measure
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
BARS: Medication Adherence
Better (Days taken less)
0 participants
3 participants
BARS: Medication Adherence
NA (Days taken less)
23 participants
22 participants
BARS: Medication Adherence
No Change (Days not taken)
17 participants
23 participants
BARS: Medication Adherence
Worse (Days not taken)
3 participants
3 participants
BARS: Medication Adherence
NA (Days not taken)
23 participants
22 participants
BARS: Medication Adherence
No Change (Days taken less)
16 participants
19 participants
BARS: Medication Adherence
Worse (Days taken less)
4 participants
4 participants

SECONDARY outcome

Timeframe: Baseline-6 months.

Provider-Patient Clinical Alliance will be assessed with Scale to Assess the Therapeutic Relationship - Patient to measure patient perspective of provider-patient relationship. This 12-item measure employing a 5-point likert scale has been used extensively in studies of outpatient care for severe mental illness. This measure supports patient and provider versions. Higher values are better. Range 0-48.

Outcome measures

Outcome measures
Measure
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
STAR-P: Patient Relationship With Clinician
Pre-Intervention
39.3 score on a scale
Standard Deviation 6.7
37.0 score on a scale
Standard Deviation 8.4
STAR-P: Patient Relationship With Clinician
Post-Intervention
38.0 score on a scale
Standard Deviation 8.2
36.1 score on a scale
Standard Deviation 7.1
STAR-P: Patient Relationship With Clinician
Pre-Post Change
-0.9 score on a scale
Standard Deviation 8.5
-1.9 score on a scale
Standard Deviation 7.3

SECONDARY outcome

Timeframe: Baseline-6 months.

The Heinrichs-Carpenter Quality of Life Scale, has 21 items, is well validated for schizophrenia, and captures sense of purpose, motivation, emotional and social interaction, role functioning, and engagement in regular activities. Higher values are better. Range 0-126. Pre-post change scores were calculated by subtracting the pre-score from the post score (= post - pre).

Outcome measures

Outcome measures
Measure
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
QLS: Heinrichs-Carpenter Quality of Life Scale
Pre-Post Change
-4.6 score on a scale
Standard Deviation 30.1
4.2 score on a scale
Standard Deviation 19.2
QLS: Heinrichs-Carpenter Quality of Life Scale
Pre-Intervention
77.4 score on a scale
Standard Deviation 19.1
79.2 score on a scale
Standard Deviation 23.4
QLS: Heinrichs-Carpenter Quality of Life Scale
Post-Intervention
63.2 score on a scale
Standard Deviation 36.9
70.1 score on a scale
Standard Deviation 43.4

SECONDARY outcome

Timeframe: Baseline-6 months.

Schizophrenia-specific symptomatology will be assessed with the Positive and Negative Syndrome Scale. Lower values are better. Range 30-210. Pre-post change scores were calculated by subtracting the pre-score from the post score (= post - pre).

Outcome measures

Outcome measures
Measure
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
PANSS: Schizophrenia Symptoms
Post-Intervention
48.0 score on a scale
Standard Deviation 11.6
45.1 score on a scale
Standard Deviation 17.5
PANSS: Schizophrenia Symptoms
Pre-Post Change
-6.1 score on a scale
Standard Deviation 14.3
-10.2 score on a scale
Standard Deviation 14.0
PANSS: Schizophrenia Symptoms
Pre-Intervention
54.0 score on a scale
Standard Deviation 14.4
56.1 score on a scale
Standard Deviation 16.0

SECONDARY outcome

Timeframe: Baseline-6 months.

Global Appraisal of Individual Needs- Short Screener (GAIN-SS) - Instrument used for screening possible internalizing or externalizing psychiatric disorders, substance use disorders, or crime and violence problems. Lower values are better. Range 0-20. Pre-post change scores were calculated by subtracting the pre-score from the post score (= post - pre).

Outcome measures

Outcome measures
Measure
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
GAIN-SS
Pre-Intervention
5.1 score on a scale
Standard Deviation 5.3
5.8 score on a scale
Standard Deviation 5.8
GAIN-SS
Post-Intervention
3.3 score on a scale
Standard Deviation 4.5
5.1 score on a scale
Standard Deviation 5.7
GAIN-SS
Pre-Post Change
-1.2 score on a scale
Standard Deviation 3.7
0.2 score on a scale
Standard Deviation 5.5

SECONDARY outcome

Timeframe: Baseline-6 months.

The 5-item, 6-point likert scale Medical Outcomes Study general adherence scale to capture broader adherence to treatment recommendations (again triangulated with provider responses). Higher values are better. Range 5-26. Pre-post change scores were calculated by subtracting the pre-score from the post score (= post - pre).

Outcome measures

Outcome measures
Measure
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
MOS: Treatment Adherence - General
Pre-Intervention
25.5 score on a scale
Standard Deviation 4.5
23.2 score on a scale
Standard Deviation 6.1
MOS: Treatment Adherence - General
Post-Intervention
23.2 score on a scale
Standard Deviation 5.8
23.0 score on a scale
Standard Deviation 5.9
MOS: Treatment Adherence - General
Pre-Post Change
-2.1 score on a scale
Standard Deviation 5.9
-0.5 score on a scale
Standard Deviation 4.9

SECONDARY outcome

Timeframe: Baseline-6 months.

Population: No show vs. attending rates for both arms do not add up to 100% since an additional measure of cancelled rates was measured in the RCT. However, this variable was excluded from analysis since in the client's medical records it is unclear whether the clinician or client cancelled the appointment.

The average rate of scheduled appointments attended through EMR audit at CAMH or provider report at non-CAMH sites. No show vs. attending rates for both arms do not add up to 100% since an additional measure of cancelled rates was measured in the RCT. However, this variable was excluded from analysis since in the client's medical records it is unclear whether the clinician or client cancelled the appointment.

Outcome measures

Outcome measures
Measure
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
Appointment Attendance
Attending Rate
82 percentage of scheduled visits
Standard Deviation 21
84 percentage of scheduled visits
Standard Deviation 18
Appointment Attendance
No-Show Rate
11 percentage of scheduled visits
Standard Deviation 19
9 percentage of scheduled visits
Standard Deviation 17

SECONDARY outcome

Timeframe: Baseline - 6 months

Population: Only a subset of the participants had their clinician participate in the study with them.

Provider-Patient Clinical Alliance will be assessed with Scale to Assess the Therapeutic Relationship - Patient to measure patient perspective of provider-patient relationship. This 12-item measure employing a 5-point likert scale has been used extensively in studies of outpatient care for severe mental illness. This measure supports patient and provider versions. Higher values are better. Range 0-48. Pre-post change scores were calculated by subtracting the pre-score from the post score (= post - pre).

Outcome measures

Outcome measures
Measure
Participants
n=18 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
n=17 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
STAR-C: Clinician Relationship With Patient
Pre-Intervention
36.2 score on a scale
Standard Deviation 3.7
36.9 score on a scale
Standard Deviation 2.9
STAR-C: Clinician Relationship With Patient
Post-Intervention
20.8 score on a scale
Standard Deviation 18.3
17.4 score on a scale
Standard Deviation 18.7
STAR-C: Clinician Relationship With Patient
Pre-Post Intervention
-3.2 score on a scale
Standard Deviation 10.5
-0.9 score on a scale
Standard Deviation 3.8

SECONDARY outcome

Timeframe: baseline - 6 months

Service Use History measure to assess past month service use history. Number of visits due to physical health issues (in the past 6 months) included the sum of: family doctor, ER, walk-in clinic, and other services Number of visits due to mental health issues (in the past 6 months) included the sum of: sum of family doctor, outpatient, psychologist, social worker, community service There is no limit on the scale range since it is based on the number of visits to various services in the past 6 months.

Outcome measures

Outcome measures
Measure
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
SUH - Patients
Physical Health Appointment Baseline
5.3 service use visits
Standard Deviation 6.6
3.8 service use visits
Standard Deviation 4.4
SUH - Patients
Physical Health Appointment Follow-up
1.8 service use visits
Standard Deviation 1.5
4.2 service use visits
Standard Deviation 13.4
SUH - Patients
Mental Health Appointment Baseline
3.6 service use visits
Standard Deviation 4.6
3.9 service use visits
Standard Deviation 4.4
SUH - Patients
Mental Health Appointment Follow-up
13.2 service use visits
Standard Deviation 16.7
11.0 service use visits
Standard Deviation 10.2

SECONDARY outcome

Timeframe: Baseline - 6 months

Population: Only a subset of the participants had a clinician participate with them.

Service Use History measure to assess past month service use history of patient participant. Number of visits due to physical health issues (in the past 6 months) included the sum of: family doctor, ER, walk-in clinic, and other services for the patient participant Number of visits due to mental health issues (in the past 6 months) included the sum of: sum of family doctor, outpatient, psychologist, social worker, community service for the patient participant There is no limit on the scale range since it is based on the number of visits to various services in the past 6 months.

Outcome measures

Outcome measures
Measure
Participants
n=18 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
Treatment As Usual
n=14 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
SUH - Clinicians
Physical Health Appointments Baseline
1.1 service use visits
Standard Deviation 0.6
0.8 service use visits
Standard Deviation 0.4
SUH - Clinicians
Physical Health Appointments Follow-up
1.7 service use visits
Standard Deviation 1.2
1.7 service use visits
Standard Deviation 0.6
SUH - Clinicians
Mental Health Appointments Baseline
6.4 service use visits
Standard Deviation 5.4
8.1 service use visits
Standard Deviation 7.1
SUH - Clinicians
Mental Health Appointments Follow-up
5.4 service use visits
Standard Deviation 2.4
2.8 service use visits
Standard Deviation 2.3

Adverse Events

A4i Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Treatment As Usual

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Sean Kidd

Centre for Addiction and Mental Health

Phone: 416-535-8501

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place